Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Regimens for Management of Empyema
NCT06787885Completed
- Sponsor
- Fayoum University
- Start
- May 2024
- Primary completion
- May 2026
- Modality
- Reversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Trial of levofloxacin, clindamycin and cefepime in pleural empyema (2 arms), sponsored by Fayoum University. Primary endpoint: Evaluation of different antibiotics at 2 weeks. Started May 2024; status: completed.
02
Drugs
levofloxacinclindamycincefepime
03
Conditions
pleural empyema
Beyond the preview
Go deeper on NCT06787885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06787885.